Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 53, Issue 9

Issues

Hemoglobin measurements in samples containing hemoglobin-based oxygen carriers

Françoise Arnaud
  • Corresponding author
  • NeuroTrauma Department, Operational and Undersea Medicine Directorate, Naval Medical Research Center, Silver Spring, MD, USA
  • Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Donna G. Sieckmann
  • NeuroTrauma Department, Operational and Undersea Medicine Directorate, Naval Medical Research Center, Silver Spring, MD, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Richard M. McCarron
  • NeuroTrauma Department, Operational and Undersea Medicine Directorate, Naval Medical Research Center, Silver Spring, MD, USA
  • Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Paula F. Moon-Massat
  • NeuroTrauma Department, Operational and Undersea Medicine Directorate, Naval Medical Research Center, Silver Spring, MD, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2015-04-16 | DOI: https://doi.org/10.1515/cclm-2015-0197

References

  • 1.

    Elmer J, Alam HB, Wilcox SR. Hemoglobin-based oxygen carriers for hemorrhagic shock. Resuscitation 2012;83:285–92.Web of ScienceGoogle Scholar

  • 2.

    Chen JY, Scerbo M, Kramer G. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics 2009;64:803–13.Web of ScienceGoogle Scholar

  • 3.

    Boura C, Caron A, Longrois D, Mertes PM, Labrude P, Menu P. Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock 2003;19:176–82.CrossrefPubMedGoogle Scholar

  • 4.

    Arnaud F, Fasipe D, Philbin N, Rice J, Flournoy WS, Ahlers S, et al. Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care. Transfusion 2007;47:2098–109.Web of ScienceGoogle Scholar

  • 5.

    Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi M, Greenburg AG. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg 2010;110:685–93.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 6.

    Nho K, Glower D, Bredehoeft S, Shankar H, Shorr R, Abuchowski A. PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model. Biomat Artif Cells Immob Biotech 1992;20:511–24.Google Scholar

  • 7.

    Belcher JD, Young M, Chen C, Nguyen J, Burhop K, Tran P, et al. MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice. Blood 2013;122:2757–64.Web of ScienceGoogle Scholar

  • 8.

    Rousselot M, Delpy E, Drieu La Rochelle C, Lagente V, Pirow R, Rees JF, et al. Arenicola marina extracellular hemoglobin: a new promising blood substitute. Biotech J 2006;1:333–45.Google Scholar

  • 9.

    Harrington JP, Wollocko H. Pre-clinical studies using OxyVita hemoglobin, a zero-linked polymeric hemoglobin: a review. J Artif Organ 2010;13:183–8.Google Scholar

  • 10.

    Estrada RR. Are i-STAT results adversely affected by an artificial blood substitute in vivo? Mil Med 2006;171:381–8.Google Scholar

About the article

Corresponding author: Françoise Arnaud, PhD, Hematology, Naval Medical Research Center, NeuroTrauma Department, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500, USA, Phone: +1 301 3197687, E-mail: ; NeuroTrauma Department, Operational and Undersea Medicine Directorate, Naval Medical Research Center, Silver Spring, MD, USA; and Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA


Received: 2015-02-25

Accepted: 2015-02-26

Published Online: 2015-04-16

Published in Print: 2015-08-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 53, Issue 9, Pages e219–e222, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2015-0197.

Export Citation

©2015 by De Gruyter.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Francoise Arnaud, Adam Higgins, Richard McCarron, and Paula F. Moon-Massat
Artificial Cells, Nanomedicine, and Biotechnology, 2017, Volume 45, Number 1, Page 58
[2]
Mario Thevis, Tiia Kuuranne, Katja Walpurgis, Hans Geyer, and Wilhelm Schänzer
Drug Testing and Analysis, 2016, Volume 8, Number 1, Page 7

Comments (0)

Please log in or register to comment.
Log in